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The clinical effectiveness of primary and secondary headache treatment by transcranial
direct current stimulation (tDCS) with various locations of stimulating electrodes on the
scalp was analyzed retrospectively. The results of the treatment were analyzed in 90
patients aged from 19 to 54 years (48 patients had migraine without aura, 32 – frequent
episodic tension-type HAs, 10 – chronic tension-type HAs) and in 44 adolescents aged 11–
16 years with chronic post-traumatic HAs after a mild head injury. Clinical effectiveness of
tDCS with 70–150µA current for 30–45min via 6.25 cm2 stimulating electrodes is compa-
rable to that of modern pharmacological drugs, with no negative side effects.The obtained
result has been maintained on average from 5 to 9months. It has been demonstrated that
effectiveness depends on localization of stimulating electrodes used for different types of
HAs.
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INTRODUCTION
Over the past decade, transcranial direct current stimulation
(tDCS) has been more widely used as a mean of neuromodu-
lation for targeted alteration of CNS structures excitability not
only in neurophysiological (Wassermann et al., 2008; Stagg and
Nitsche, 2011), but also in clinical studies for treatment of depres-
sions (Nitsche et al., 2009), stroke consequences (Schlaug et al.,
2008), pain syndrome (Fregni et al., 2006; Zaghi et al., 2009), and
other effects.
Stimulation by low-intensity direct current, or so-called gal-
vanization, is not new. Galvanizations had been widely used
worldwide from the beginning of nineteenth till the beginning
of twentieth century; it gradually gave place to impulse stimu-
lations with more predicable results (Lolas, 1977). Fundamental
physiological basis of one of galvanization types, called tDCS in
Europe and the USA, or transcranial micropolarization (TCMP)
in Russia, including safety issues and general principles of clinical
use, have already been stated in the 1970s and 1980s in the works
of Institute of Experimental Medicine (Saint Petersburg) (Var-
tanian et al., 1981). We started to use tDCS in a clinical practice
since 1988. We published first reports on its successful use in chil-
dren with cerebral palsy as far back as in 1994 (Bogdanov et al.,
1994). The method of brain galvanization (transcranial direct
current stimulation, one of the types of which is the tDCS) is
officially approved in the Russian Federation (Order No. 1440 of
Abbreviations: 1EP, first electrode position; 2EP, second electrode position; 3EP,
third electrode position; ANS, autonomic nervous system; CPTH, chronic post-
traumatic headache related to a mild head injury; CTTH, chronic tension-type
headache; EEG, electroencephalography; FETTH, frequent episodic tension-type
headache; HA, headaches; ICHD-II, international classification of headache disor-
ders (2004); NRS, numerical rating scale; RF, reticular formation; tDCS, transcranial
direct current stimulation; TTH, tension-type headache.
21.12.1984 by the Ministry of Health of the USSR, and Orders of
12.07.2004 and 27.12.2011 No. 1664n“On approval of the nomen-
clature of medical services” by the Ministry of Health and Social
Development of the Russian Federation) subject to the following
rules: voltage up to 50 V, current up to 10 mA, current density for
adults 0.05–0.3 mA/cm2, for children of 5–12 months not more
than 0.03 mA/cm2, with age the current density increases up to
0.08 mA/cm2 (in children 15–16 years of age), exposure time from
10 to 40 min.
Nowadays, tDCS is a routine technique used for various
pathologies at the Saint Petersburg Municipal Center for Med-
ical Rehabilitation of Children with Psychoneurological Disorders
(Pinchuk, 2007). Since 1988 till 2011, more than 1400 children and
adolescents aged from 9 months to 17 years and more than 350
adult patients with various nervous system diseases have under-
gone tDCS treatment in the Center. tDCS procedures appeared
to be also effective in the treatment of headaches (HA). Based
on results obtained we tried to identify the possible mechanisms
underlying the clinical effectiveness tDCS in the treatment of HA.
We are aware that this work is as yet incomplete but taking
into consideration the importance of the problem, great number
of patients with HA, combined with the high degree of effective-
ness of the technique and almost complete absence of undesirable
effects, we consider advisable to inform specialists working in this
field of our experience in using tDCS technique for HA treatment.
AIM
The objective of this work is to provide a retrospective analysis of
the results of the treatment of patients with HA by means of tDCS
with various localizations of stimulating electrodes on the scalp
and to define possible mechanisms of action at these positions for
various types of HA.
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MATERIALS AND METHODS
The retrospective study was utilized to evaluate the results of tDCS
treatment in patients with different types of primary and sec-
ondary HAs. We did not conduct trials using simulated tDCS,
nor did we use control groups or compare the efficacy of alter-
native treatment; we confined ourselves to comparing our results
with the published data of other authors on the efficacy of the
pharmacological treatment of patients with HAs. The data of
clinical studies, which were included in the standard tDCS pro-
tocol used in our Center, have been analyzed. Protocol includes
reports by the patients themselves (parental reports for children),
results of electroencephalographic (EEG) investigation (an oblig-
atory procedure when selecting patients for tDCS treatment) and
brief Lüscher test with eight colors (Sobchik, 2001). In specific
cases, MRI and CT were used, as well as ultrasound examination
of brain vessels and vessels of vertebrobasilar basin was conducted
in order to exclude symptomatic HA.
In addition for adult patients a visual pain scale (Numerical
Rating Scale – NRS) from 0 to 10 (Belova and Shepetova, 2002),
Beck Depression Inventory (Belova and Shepetova, 2002), and
Spielberger’s State-Trait Anxiety Inventory, adapted by Khanin
(1976) for local conditions, were used. Among 165 persons receiv-
ing tDCS sessions for HA, patients were selected whose HA
symptoms corresponded to diagnostic criteria of International
Classification of Headache Disorders (ICHD-II) (Headache Clas-
sification Subcommittee of the International Headache Society,
2004), which allowed us to classify them as the certain type of
primary HA – migraine without aura (ICHD-II 2004 code 1.1), fre-
quent episodic tension-type HA (FETTH) (ICHD-II 2.2), chronic
tension-type HA (CTTH) (ICHD-II 2.3), and secondary HA –
chronic post-traumatic HA related to a mild head injury (CPTH)
(ICHD-II 5.2.2).
We analyzed the results of HA treatment in 90 adults aged
from 19 to 54 (mean age 29.4± 12.8 years), 71% (64 persons)
were women and 29% (26 persons) were men, and also treatment
results of 44 adolescents (38 boys and 6 girls aged from 11 to 16;
mean age 13.6± 2.5 years).
In the analyzed groups we used three basic localizations of
stimulating electrodes on the scalp out of 17 used during tDCS.
For the first electrode position (1EP), an anode was placed over
the frontal pole (medial edge of the electrode was situated at the
boundary of the interhemispheric fissure) of the hemisphere sub-
dominant in motor skills; a cathode was located at the ipsilateral
mastoid process.
For the second electrode position (2EP), an anode was placed
in the center of the forehead, 1.5 cm above the nasal bridge, at the
projection of the interhemispheric fissure; a cathode was placed
2 cm higher the mastoid process of the hemisphere subdominant
in motor skills.
For the third electrode position (3EP), an anode was placed
in the center of the frontal pole of subdominant hemisphere; a
cathode was placed 2 cm above the ipsilateral mastoid process.
Stimulation time was 30–45 min both in children and adults;
current intensity ranged from 60 to 90µA for children to 100–
150µA for adults; electrodes were made of medical conductive
rubber and were placed in 6.25 cm2 saline-soaked multilayer
flannel cases. The current densities we use (0.001–0.024 mA/cm2)
almost do not differ from those used in majority of studies on
tDCS (0.029–0.066 mA/cm2) (Bastani and Jaberzadeh, 2012), and
they are in the range permitted by the Ministry of Health of the
USSR (now the Russian Federation) when performing transcra-
nial stimulation with galvanic (direct) current (0.01–0.2 mA/cm2).
By the way, these figures are almost the same as the parame-
ters of current density which were used at the end of nine-
teenth to twentieth centuries (0.01–0.3 mA/cm2). The time of
stimulation we use (30–45 min) is somewhat longer than the
one traditionally used in procedures of tDCS (10–20 min). How-
ever, in several studies (Schlaug and Renga, 2008) longer time
is used (up to 30 min). Lengthening the time of exposure leads
to greater charge of electricity than during the traditional use;
tDCS – 0.09–0.12 C/cm2, where 1 C is the amount of electric
charge transported in 1 s by a steady current of 1 A (Stagg and
Nitsche, 2011), in our studies these values range from 0.19 to
0.26 C/cm2. Although, there are works where these values are
higher than the ones we used. So in the study of Schlaug and
Renga (2008) the maximum total charge was 2.4 C/cm2. How-
ever, in this case the values are much lower than the acceptable
safety regulations (up to 200 C/cm2) (Yuen et al., 1981). The num-
ber of procedures for a course varied from five to nine with
4–7 days interval. Stabilization of HA level was a criterion for
treatment course completion. Treatment was conducted in com-
pliance with modern generally accepted standards of biomedical
ethics.
The main parameter of treatment effectiveness included a
decrease in number of days with HA per month by 50% or more,
compared with baseline prior to the treatment; secondary para-
meters included HA intensity and duration, amount of analgesics
used, depression, and anxiety scale parameters. Parameters prior
to and after the treatment were compared between the groups
using the Wilcoxon non-parametric test for paired comparisons
of dependent samples and also the non-parametric Spearmen
correlations (Statistica, StatSoft, version 6.1).
RESULTS
The group with migraine consisted of 48 patients aged 19–54
(32.9± 10.3) years: 79% (38 persons) were women, 21% (10 per-
sons) – men; the mean duration of disease was 11.7± 10.1 years.
Characteristic of patients is presented in Table 1.
Unspecific diffuse changes in bioelectrical activity (BA) of
varying degrees were revealed on ECGs of almost all patients
with migraine. Even though the picture of EEGs of patients with
migraine is polymorphic, two groups can be identified.
Electroencephalographic changes typical for dysfunction of
brain stem oral departments with activation of its structures were
observed in the first group (Niedermeyer and Lopes da Silva,
1999). Decreased α´-rhythm amplitude and index, up to a complete
disappearance of the rhythm, smoothing of regional differences,
domination of low-amplitude polymorphic slow activity distorted
by flashes of regular θ-rhythm in frontal leads and bilateral syn-
chronic flashes of β-rhythm in temporal and frontal leads were
observed. The range of reaction of adopting the photostimulation
rhythm was increased (from 2 to 24 Hz). Virtually no epileptiform
activity and focal changes were observed on EEGs of patients in
this subgroup.
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Table 1 | Results of tDCS treatment of various HA types (in analyzed groups in general).
Migraine (48 persons) FETTH (32 persons) CPTH (44 persons) CTTH (10 persons)
Before After Before After Before After Before After
NRS score 7.52±2.38 3.92±2.84*** 5.52±1.94 3.26±2.51** 5.11±1.6 2.11±1.54*** 5.76±2.53 3.62±2.44
Number of days with
HA per month
4.71±1.53 1.44±2.27*** 8.83±3.51 4.97±4.67** 10.32±6.48 4.11±2.18*** 21.77±5.34 17.43±7.66




14.22±6.54 10.21±4.11** 17.22±6.54 13.28±3.71* – – 12.54±5.63 10.81±6.75
Level of trait anxiety
(score) (by Spielberger)
44.85±9.75 40.15±11.35* 48.14±11.61 43.67±7.34 – – 32.95±5.61 30.48±5.37
Level of state anxiety
(score) (by Spielberger)
42.77±8.21 36.43±15.1** 51.17±9.17 42.04±11.18*** – – 36.02±7.11 29.28±6.75*
Amount of analgesics
taken (tablets/month)
12.07±8.62 5.27±3.48*** 10.16±4.23 7.43±3.31* – – 16.10±6.62 13.11±4.25
All values are provided in M± σ format. Values prior to and after the treatment significantly differed according to the paired Wilcoxon test for dependent samples at
the level (*p<0.05, **p<0.01, ***p<0.001).
On EEGs of the second group the following was observed:
increased amplitude of α´-rhythm (more than 120µV), increase of
its index to 70–80%, α´-rhythm frequency instability, its improper
distribution (it was registered in frontal leads), and distortion of α´-
rhythm by flashes of regular θ-rhythm (5–6 Hz) in frontal and cen-
tral leads. The range of adopting the rhythm of photostimulation
increased from 2 to 22 Hz.
Epileptiform activity was registered in some patients (single
slow spikes, reduced epi-complexes, and paroxysmal activity when
conducting stress tests). These alterations are observed at dien-
cephalic structures dysfunction (Niedermeyer and Lopes da Silva,
1999).
Patients with the first type of EEG composed 35% and about
40% with the second type; approximately 10% of EEGs of patients
with migraine were normal, 15% of the patients had a mixed EEG
type.
The group of patients with FETTH consisted of 32 patients aged
from 24 to 49 (33.6± 12.3): 23 women (72%) and 9 men (28%).
In 65% (21 persons) HA was associated with pericranial tender-
ness (ICHD-II 2004 code 2.2.1), 11 patients had no pericranial
tenderness (code 2.2.2).
An α´-rhythm, with significantly decreased index and ampli-
tude, insufficiently modulated and desynchronized, was registered
on EEGs of majority of the patients with FETTH. Slow activity
manifested as low-amplitude polymorphic slow activity. Consid-
erable elevation of excitability processes was observed, which was
reflected in generalized adopting of reaction on photostimulation
in the wide range of frequencies (from 2 to 24 Hz), and also in α´-,
θ-, and β-waves flashes in frontal leads.
The group of patients with CTTH consisted of 10 women
aged from 31 to 52 (35.2± 11.8) with HA during 17–26 days a
month (19.77± 5.34 on average). Pain pattern corresponded to
ICHD-II (Headache Classification Subcommittee of the Interna-
tional Headache Society, 2004) diagnostic criteria of CTTH except
for the article on medication overuse.
Unspecific alterations of brain BA were revealed in most cases
in EEGs of patients with CTTH: decreased amplitude and irreg-
ularity of α´-rhythm, domination of rapid waves, sharpened and
slow oscillations, smoothing of regional differences. EEGs are nor-
mal or marginal in 4 out of 10 patients. Background paroxysmal
activity as single flashes of spike waves was observed only in one
female patient.
A group of patients with CPTH related to a mild head
injury consisted of adolescents undergoing treatment in the
Center for cognitive disorders, asthenia, anxiety, vegetative dis-
turbances occurred in 6–9 months after a mild brain concus-
sion. A CTTH of moderate intensity usually occurred in the
afternoon.
Elevated spectrum intensity of α´-rhythm in frontal depart-
ments of the brain and its decrease in caudal departments, com-
bined with reduction of α´-rhythm amplitude, were observed
on EEGs. In five patients (12%), a regular θ-rhythm has been
observed in frontal and central leads. Data on effectiveness
of tDCS usage in analyzed groups in general is presented in
Table 1, and with various location of stimulating electrodes – in
Table 2.
According to patients’ self-reports, tDCS, when using the 1EP,
has led to fast HA relief (already during the first two to three ses-
sions). This localization has been more effective at CPTH and
migraine (more than in 85 and 78%, respectively), at FETTH
(52%), at CTTH (only in two patients out of seven, i.e., 29%).
The 1EP was more effective in patients with dominating increased
tonus of parasympathetic nervous system (according to Lüscher
test – so-called criterion of vegetative balance) (Belova and
Shepetova, 2002).
With migraine, the number of attacks decreased; if developed,
they were shorter and less intensive. The pattern of HAs changed:
during the attack, HA was dull instead of acute and disappeared
rather fast. Duration of pain attack reduced from 9–24 to 3–8 h.
The number of vegetative manifestations (flushes, feeling hot,
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Table 2 | Effectiveness of treatment with various localizations of stimulating electrodes on the scalp for various HA types.
Positions of stimulating
electrodes on the scalp
Migraine (48 persons) FETTH (32 persons) CPTH (44 persons) CTTH (10 persons)
1 2 3 1 2 3 1 2 1 3
Number of patients in the group 33 13 2 18 10 4 38 6 3 7
HA absence for at least
4.5months
9 (27%) 3 (23%) – 4 (22%) 3 (30%) – 20 (52%) – –
Reduction of the number of days
with HA at least by 50%
compared with baseline for at
least 4.5months
17 (51%) 8 (62%) – 6 (33%) 5 (50%) 2 (50%) 11 (29%) 2 (33%) – 2 (29%)
Total improvement 26 (78%) 11 (85%) – 10 (55%) 8 (50%) 2 (50%) 33 (81%) – –
No effect 6 (19%) 2 (15%) 2 (100%) 7 (39%) 1 (10%) 2 (50%) 7 (19%) 4 (66%) 3 (100%) 5 (71%)
Worsening of condition 1 (3%) – – 1 (6%) 1 (10%) – – –
sweating, nausea, etc.) sharply decreased. Amount of analgesics,
relieving the attack, decreased from 2–6 to 1–2 tablets.
Out of 33 patients with migraine who received tDCS at the 1EP,
HA became worse only in one 42-year-old female patient after the
second tDCS session; as a result this the patient refused to con-
tinue treatment. HA intensity in this patient decreased to baseline
in 2 weeks after treatment termination and remained at that level
throughout 3 months of follow-up.
Subjective self-assessment of HA level in the group of patients
with migraine when using the 1EP has significantly decreased by
NRS score (on average by 3.01; from 7.32± 1.54 to 4.31± 1.82
after the treatment) according to the Wilcoxon test (p= 0.0024).
Depression level significantly decreased according to Beck Inven-
tory (from 13.81± 5.19 to 10.01± 3.94, p= 0.044).
Not only the level of state anxiety but also the level of trait anx-
iety statistically significantly decreased according to Spielberger’s
Inventory. Significant Spearman correlations (p< 0.05) of NRS
subjective pain assessment were observed for the level of state anx-
iety only, but not for the trait one. Duration of obtained sustained
clinical alterations, as a rule, was at least 5 months (6–8 months on
average). The longest recorded result was 2.5 years.
After tDCS course in patients with CPTH, along with marked
reduction in HA level, the following was observed: significant
reduction of asthenic syndrome manifestations (reduced tired-
ness and irritancy, normalization of sleep), reduction, and in
some patients almost complete disappearance of vegetative lability
symptoms. In 52% of patients with CPTH, after tDCS course HA
completely disappeared for at least 4.5 months; in 28% of patients
the number of days with HA decreased by at least 50% from base-
line for at least 4.5 months; tDCS had no effect in 20% of patients.
Subjective assessment of HA level in patients with CPTH decreased
by 3.5 points on average in the group (from 5.4± 1.8 prior to the
treatment to 1.9± 1.2 after tDCS course, p= 0.0006).
After tDCS course, in patients with FETTH the feeling of head
compression reduced significantly or completely disappeared, the
number of days without HA increased, amount of analgesics
being taken reduced. Level of pain in patients with FETTH when
using the 1EP reduced by 1.88 points on average in the group
(4.92± 2.89 prior to the treatment, 3.04± 2.82 after the treatment,
p= 0.062). Positive clinical effect was obtained mainly due to the
subgroup of patients with TTH combined with muscular tender-
ness of pericranial muscles. Out of 18 patients with TTH, receiving
tDCS in the 1EP, TTH combined with pericranial tenderness was
observed in 13 patients. Out of these 13 patients, HAs completely
disappeared in 4 patients for a period longer than 4.5 months;
in 6 patients, the number of days with HA reduced by at least
50% compared with baseline for a period longer than 4.5 months;
only in 3 patients no effect was observed. tDCS clinical effective-
ness assessed by the decrease of days with HA in total is 76.9% in
the subgroup of patients with FETTH combined with pericranial
tenderness. According to NRS, reduction of HA intensity is sig-
nificant (from 5.05± 3.01 prior to the treatment to 2.87± 2.11,
p= 0.0429). Reduction of HA intensity significantly (p< 0.05)
correlated (by Spearman) both with decrease of depression level
by Beck Inventory and with decrease of state anxiety level by Spiel-
berger’s Inventory. In all five patients with FETTH not associated
with pericranial tenderness, tDCS with the 1EP was ineffective.
Treatment course was terminated after the third procedure in a
35-years old female patient due to increasing of HAs accompanied
with vegetative manifestations (dizziness, nausea). In a week after
treatment termination, HA stabilized at the former level.
Obtained positive effect in patients with FETTH has pre-
served for at least 6 months (8–10 months on average); the longest
recorded positive result was 18 months.
Neither decreased number of days with HA nor reduced HA was
revealed in three patients with CTTH with the 1EP used; although
no intensification of HA was either observed.
The 2EP was more effective at migraine with moderate pain
attacks and with dominating moderately increased tonus of sym-
pathetic autonomic nervous system (ANS). Out of 13 patients
with migraine, receiving tDCS sessions, the shift of vegetative
balance toward domination of sympathetic ANS was observed
in 10 patients according to Lüscher test, and positive clinical
response (complete disappearance or reduction of days with HA
by 50% compared with baseline) was obtained in all of them.
Reduced intensity of HAs by NRS from 7.78± 1.68 to 5.23± 1.19
(p= 0.002) was observed. Out of three patients with migraine,
who had a shift of vegetative balance toward domination of
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parasympathetic ANS, reduced HA was observed in only one
patient.
The 2EP was effective in some patients with FETTH, mainly at
TTH not combined with pericranial tenderness. Out of 10 patients
with TTH, receiving tDCS treatment with the 2EP, there were 6
patients with TTH not combined with pericranial tenderness. At
that, clinical improvement was observed in five of them; all three
patients, whose HAs disappeared for at least 4.5 months, had TTH
not combined with pericranial tenderness. Improvement was reg-
istered only in two out of four patients with FETTH combined
with pericranial tenderness: no effect was observed in one patient,
and one patient terminated treatment due to intensification of
HA.
The 2EP was used in six patients with CPTH. Treatment was
effective only in two girls aged 13 and 13.5 years. In four boys
(aged from 9 to 11 years) treatment was ineffective. “Mildness”
of treatment effect, which progressively increased at every session
and stabilized by sessions five to seven, is an advantage of using
the 2EP.
Out of all positions used, the 3EP was the most effective at
CTTH (although it is rather conditional, as some improvement
was observed only in two out of six patients).
DISCUSSION
Although TTH and migraine are traditionally considered to be
different diseases, a significant clinical effectiveness of the same
electrode localization (the 1EP) at tDCS both in patients with
migraine and in patients with TTH rather indicates common
pathophysiological mechanisms in these HA types. We tend to
agree with D. Greenberg et al. (2005), who consider migraine and
TTH to be two opposite poles of a single clinical spectrum. Psy-
chosocial stress is believed to be a provoking factor for TTH,
and personality traits (high incidence of anxiodepressive and
somatoform disorders) predispose to development of cephalgia
(Karakulova, 2006). However, these factors and, in particular, anx-
iodepressive syndrome of varying degrees are revealed in almost
60% of migraine cases (Gusev et al., 1999; Osipova and Levin,
2006). NRS HA intensity level correlated significantly with state
anxiety parameters according to Spielberger’s Inventory and Beck
Depression Inventory in our study both in patients with migraine
and in patients with TTH.
Electroencephalography in our patients with migraine (the first
type of EEG) is similar although not identical to EEG of patients
with FETTH. It is interesting that this type of EEG (decrease of
α´-rhythm index and amplitude, domination of irregular α´-, β-,
and θ-oscillations on EEG, and increased range of photostimula-
tion adoption reaction) is typical for patients with anxiodepressive
syndrome (Volynkina and Suvorov, 1981). The latter also confirms
common pathophysiological mechanisms of migraine (patients
with the first EEG type) and TTH in some cases. This explains a
positive clinical effect when using the same electrode position (the
1EP) during tDCS both in patients with migraine and in patients
with FETTH.
Apparently, changes in balance of frontal cortex activity,
its shift toward activation of left hemisphere frontal cortex,
determining the positive emotional background, is one of the
reasons for improvement following tDCS with the 1EP, taking
into consideration anxiodepressive component in HA clinical pic-
ture (Deglin and Nikolaenko, 1975; Heller, 1993). tDCS inhibitory
regimen (exposure more than 35 min) (Pinchuk, 2007) applied
on the structures of the right orbitofrontal cortex resulted in a
decrease in its activity and in reciprocal activation of the left hemi-
sphere released of the right hemisphere inhibiting influence. This
leads to a marked mood improvement, reduced anxiety, more ade-
quate assessment, and response to environment and to regression
of concurrent psychovegetative symptoms and reduction of HA
intensity.
Transcranial direct current stimulation with the 1EP has pre-
dominantly caused an increase of sympathetic ANS activity which
manifested in a feeling of energy surge, in decreased sleeping
period, however, without feeling fatigued, in increased libido
(prior to that it was decreased on average). Insignificant tran-
sitory systolic arterial pressure increase (by 5–10 mm Hg) was
observed in some patients directly after tDCS. An increased level
of sympathetic ANS activity is supposed to result in rebalancing
of parasympathetic and sympathetic ANS. Due to this fact, among
others, this localization in patients with symptoms of increased
parasympathetic ANS activity is the most effective one. How-
ever, abrupt HA reduction during tDCS cannot be explained only
by improvement of patient’s psycho-emotional condition. Alter-
ations in brainstem reticular formation (RF) and, particularly, in
mesencephalic RF during tDCS seem to play an important role in
observed effects. Activating locations with similar low threshold
for activation and inhibition reactions as in non-specific RF struc-
tures of mesencephalon and thalamus are revealed in different
cortical areas (Penfield and Jasper, 1954; Andreyeva et al., 1979).
Our results also suggest the possibility of targeted alteration in
RF functional state by influencing the modulating cortical areas
(Pinchuk, 2007).
Used localization of stimulating electrodes allowed us to influ-
ence not only the frontal pole, but also (although to a lesser
extent) the mediobasal areas of the frontal lobes, from which the
most powerful system of corticofugal fibers goes toward the RF.
Precisely by influencing these areas we can lower or increase RF
and thalamus activity to an optimal level (Tsirkin and Trukhina,
2001).
Electroencephalographic pattern in patients with migraine and
tension-type HA indicates either significantly increased excitabil-
ity of cortical elements or reduced cortical tonus, which in both
cases can indicate disturbances in functional correlations between
the cortex and mesencephalic RF in HA. Normalization of these
correlations seems to occur during tDCS.
Activation of mesencephalic RF is supposed to be the main
treatment factor when using tDCS in patients with CPTH after a
mild brain injury. The leading cause of these HAs is a reduction
of RF activating influence, leading to disorder of reticulo-cortico-
subcortical neurodynamics (Kryzhanovsky, 1986; Callaghan and
Abu-Arafeh, 2001). Thus, the 1EP, providing the most prominent
RF activation effect, is the most effective in such patients (in 85%
of patients receiving tDCS sessions).
Complaints between attacks point to a chronic dysfunction
of hypothalamic system both in patients with migraine and in
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patients with TTH. Low tolerance for different provoking fac-
tors (low “migraine threshold”), also stress and vasodilator factors
indicates the same. Improved hypothalamus functioning during
tDCS manifests in normalization of patients’ vegetative status
(improvement of psycho-emotional condition, reduced sweating
and chilliness in the arms and legs, normalization of blood pres-
sure and gastrointestinal functions, in particular, normalization
of stool in patients with long-lasting and persistent constipations
etc.). Sometimes, especially during the first sessions, when stim-
ulation regimens are chosen inadequately, symptoms registered
in experiments with direct hypothalamus stimulation (“gargan-
tuan appetite,” nausea, increased salivation, intestinal cramps etc.)
are observed directly during tDCS procedure (for 15–20 min).
These symptoms were most observed when using the 2EP, less
frequently – in the 1EP and 3EP. The above-observations sug-
gest that hypothalamus condition also changes during tDCS. It
is still unclear whether a hypothalamus condition changes due
to direct tDCS impact on the cortical areas with corticofugal
projections on the hypothalamus (possibly, during tDCS with
the 2EP), or hypothalamus activation is secondary to RF acti-
vation. The latter is more likely for the 1EP and 3EP, it can
be explained by the powerful system of reticulo-hypothalamic
relations.
Besides the above-mentioned mechanisms, cathode’s position
also plays an important role in reducing a HA. Intensity of emo-
tional feelings regardless of their type (positive or negative) and,
respectively, the level of vegetative reactions providing such emo-
tional condition depend on the state of the right post-temporal
area (Aftanas and Varlamov, 2007). Exactly this area was inhibited
by a cathode in tDCS using the 1EP and 2EP on the scalp.
Clinical effectiveness of tDCS at HA treatment (excluding
CTTH) is comparable to an effectiveness of traditional pharma-
cological drugs and to such non-traditional types of treatment as
biofeedback technique and chiropractic manipulations (Andrasik,
2010; Haag, 2010; Bryans et al., 2011). At the same time, ther-
apeutic effect was more consistent and prolonged than during
medication therapy with almost no side effects; it makes tDCS a
promising treatment option for HA of various etiologies.
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